Trial Profile
Tolerability of Nebivolol Compared With Metoprolol ER in Patients With Mild to Moderate Hypertension Taking Hydrochlorothiazide (HCTZ)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 22 May 2019
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 30 Apr 2019 Status changed from completed to discontinued.
- 05 Feb 2008 Status changed from recruiting to completed, in accordance with clinicaltrials.gov.
- 03 Nov 2007 New trial record.